Volume | 355,893 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 3.74 | Mínimo Máximo |
|||||
Minimo del Dia | 3.18 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Lexaria Bioscience Corporation | LEXX | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
3.41 | 3.18 | 3.74 | 3.27 | 3.41 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
1,359 | 355,893 | US$ 3.43 | US$ 1,219,542 | - | 0.6488 - 6.85 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
18:53:46 | 4 | US$ 3.36 | USD |
Información Financiera Lexaria Bioscience Corporation LEXX
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
0 | 10.28M | - | 226k | -6.67M | - | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Lexaria Bioscience Corporation LEXX
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
06/3/2024 | 05:00 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
01/3/2024 | 13:28 | Edgar (US Regulatory) | Form 8-K - Current report |
16/2/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
16/2/2024 | 14:47 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
14/2/2024 | 13:20 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
14/2/2024 | 11:00 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
30/1/2024 | 12:51 | Edgar (US Regulatory) | Form 8-K - Current report |
24/1/2024 | 13:12 | Edgar (US Regulatory) | Form 8-K - Current report |
24/1/2024 | 12:33 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
18/1/2024 | 13:38 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
12/1/2024 | 16:11 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
11/1/2024 | 07:30 | GlobeNewswire Inc. | Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary.. |
Histórico de Datos LEXX
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.98 | 4.44 | 3.18 | 3.84 | 353,698 | -0.71 | -17.84% |
1 Month | 3.62 | 4.44 | 2.66 | 3.46 | 321,088 | -0.35 | -9.67% |
3 Months | 3.81 | 4.44 | 1.85 | 3.31 | 295,671 | -0.54 | -14.17% |
6 Months | 1.49 | 6.85 | 1.20 | 3.31 | 343,686 | 1.78 | 119.46% |
1 Year | 0.75 | 6.85 | 0.6488 | 2.80 | 223,397 | 2.52 | 336.00% |
3 Years | 6.84 | 12.50 | 0.6488 | 4.94 | 300,688 | -3.57 | -52.19% |
5 Years | 4.05 | 12.50 | 0.6488 | 5.24 | 349,212 | -0.78 | -19.26% |